Skip to content

Yale Suspends Support for Open Access Publisher

Science and medical libraries at Yale have announced that they are suspending financial support for Yale authors publishing in BioMed Central, an open access repository.

Yale’s post argued: “While the technology proved acceptable, the business model failed to provide a viable long-term revenue base built upon logical and scalable options.”  Reading the rest of Yale’s post, the decision clearly has less to do with BioMed Central’s business model in isolation and more to do with conflicts between BioMed Central’s business model and the budgetary imperatives now imposed on Yale libraries.  Business model, meet business model.  Yale, too, has to meet its numbers.